ORIC Pharmaceuticals' Series C Round

ORIC Pharmaceuticals raised a round of funding on February 21, 2018.

ORIC Pharmaceuticals is a cancer therapy company focused on the discovery and development of small-molecule drugs that target treatment-resistant cancers, beginning with advanced prostate cancer. ORIC…

Articles about ORIC Pharmaceuticals' Series C Round: